Magnetic seed versus guidewire-based breast cancer localization with magnetic lymph node detection: cost-minimization analysis - Scorecard - MDSpire

Magnetic seed versus guidewire-based breast cancer localization with magnetic lymph node detection: cost-minimization analysis

  • By

  • Eirini Pantiora

  • Filipa Sampaio

  • Allan Jazrawi

  • Fredrik Wärnberg

  • Staffan Eriksson

  • Andreas Karakatsanis

  • December 1, 2025

  • 0 min

Share

Clinical Scorecard: Cost-Effectiveness Comparison of Magnetic Seed and Guidewire Techniques for Breast Cancer Localization with Magnetic Lymph Node Detection

At a Glance

CategoryDetail
ConditionNon-palpable breast cancer requiring lesion localization and sentinel lymph node biopsy
Key MechanismsMagnetic seed localization combined with superparamagnetic iron oxide nanoparticles for SLN detection versus traditional guidewire localization
Target PopulationAdults with non-palpable cTis–T3 N0 breast cancer undergoing breast-conserving surgery and sentinel lymph node biopsy
Care SettingSurgical oncology in hospital operating theatres with preoperative radiology and surgical teams

Key Highlights

  • Magnetic seed localization shows comparable clinical performance to guidewire with shorter operating times and higher staff satisfaction.
  • Adjusted cost analysis demonstrated an 11.1% reduction in total costs with magnetic seed despite higher device cost.
  • Magnetic technique streamlines logistics by allowing preoperative placement days before surgery, reducing scheduling challenges.

Guideline-Based Recommendations

Diagnosis

  • Use magnetic seed or guidewire for preoperative localization of non-palpable breast lesions.
  • Perform sentinel lymph node biopsy using superparamagnetic iron oxide nanoparticles for magnetic detection.

Management

  • Consider magnetic seed localization to reduce operating time and improve workflow efficiency.
  • Employ a totally magnetic approach combining magnetic seed and SPIO for lesion and lymph node localization.

Monitoring & Follow-up

  • Monitor localization success rates, operating times, and re-excision rates to assess technique effectiveness.
  • Collect patient-reported outcome and experience measures to evaluate satisfaction.

Risks

  • Be aware of potential localization failures; magnetic seed showed fewer failures compared to guidewire.
  • Consider device cost implications and resource utilization in decision-making.

Patient & Prescribing Data

426 patients with non-palpable breast cancer, median age 65 years, median BMI 26.6 kg/m2

Magnetic seed localization is cost-effective with reduced operating time and process streamlining, despite higher device cost (€278 vs €38 for guidewire).

Clinical Best Practices

  • Schedule magnetic seed placement during preoperative consultation to decouple localization from surgery day.
  • Use superparamagnetic iron oxide nanoparticles for sentinel lymph node detection to enable a fully magnetic surgical approach.
  • Apply micro-costing methods to evaluate economic impact of localization techniques from healthcare system perspective.

References

Original Source(s)

Related Content